{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:43Z","timestamp":1781675803757,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Gansu Province","award":["23JRRA1050"],"award-info":[{"award-number":["23JRRA1050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01943-8","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:36:17Z","timestamp":1781674577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy"],"prefix":"10.1007","volume":"26","author":[{"given":"Yingwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"1943_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah EE (2022) IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med 20:347. https:\/\/doi.org\/10.1186\/s12967-022-03554-w","journal-title":"J Transl Med"},{"key":"1943_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1142838","volume":"13","author":"RI Anu","year":"2023","unstructured":"Anu RI, Shiu KK, Khan KH (2023) The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC. Front Oncol 13:1142838. https:\/\/doi.org\/10.3389\/fonc.2023.1142838","journal-title":"Front Oncol"},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner EN, Rathmell JC (2023) Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41:421\u2013433. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.009","journal-title":"Cancer Cell"},{"key":"1943_CR4","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1016\/j.apsb.2024.07.004","volume":"14","author":"Y Bao","year":"2024","unstructured":"Bao Y, Qiao J, Gong W, Zhang R, Zhou Y, Xie Y, Xie Y, He J, Yin T (2024) Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway. Acta Pharm Sin B 14:4461\u20134477. https:\/\/doi.org\/10.1016\/j.apsb.2024.07.004","journal-title":"Acta Pharm Sin B"},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/0008-5472.can-18-0668","volume":"79","author":"KS Bishnupuri","year":"2019","unstructured":"Bishnupuri KS, Alvarado DM, Khouri AN, Shabsovich M, Chen B, Dieckgraefe BK, Ciorba MA (2019) IDO1 and kynurenine pathway metabolites activate PI3K-Akt signaling in the neoplastic colon epithelium to promote cancer cell proliferation and inhibit apoptosis. Cancer Res 79:1138\u20131150. https:\/\/doi.org\/10.1158\/0008-5472.can-18-0668","journal-title":"Cancer Res"},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"1943_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347492","volume":"15","author":"AC Burk","year":"2024","unstructured":"Burk AC, Apostolova P (2024) Metabolic instruction of the graft-versus-leukemia immunity. Front Immunol 15:1347492. https:\/\/doi.org\/10.3389\/fimmu.2024.1347492","journal-title":"Front Immunol"},{"key":"1943_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03175-5","volume":"11","author":"M Cerezo","year":"2020","unstructured":"Cerezo M, Rocchi S (2020) Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy. Cell Death Dis 11:964. https:\/\/doi.org\/10.1038\/s41419-020-03175-5","journal-title":"Cell Death Dis"},{"key":"1943_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051146","author":"E Chiarella","year":"2022","unstructured":"Chiarella E, Nistic\u00f2 C, Di Vito A, Morrone HL, Mesuraca M (2022) Targeting of mevalonate-isoprenoid pathway in acute myeloid leukemia cells by bisphosphonate drugs. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10051146","journal-title":"Biomedicines"},{"key":"1943_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1409210","volume":"15","author":"M Chomczyk","year":"2024","unstructured":"Chomczyk M, Gazzola L, Dash S, Firmanty P, George BS, Mohanty V, Abbas HA, Baran N (2024) Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment. Front Pharmacol 15:1409210. https:\/\/doi.org\/10.3389\/fphar.2024.1409210","journal-title":"Front Pharmacol"},{"key":"1943_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116221","volume":"172","author":"H Cui","year":"2026","unstructured":"Cui H, Sheng A, Sun X, Li Z, Liu Y, Huangfu L, Ding J, Zheng Y, Yang D (2026) The ALKBH1\/MYC positive feedback loop regulates TAM polarization and remodels the tumor microenvironment to promote gastric cancer development. Int Immunopharmacol 172:116221. https:\/\/doi.org\/10.1016\/j.intimp.2026.116221","journal-title":"Int Immunopharmacol"},{"key":"1943_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.168065","volume":"1872","author":"GN de Queiroz","year":"2026","unstructured":"de Queiroz GN, Lima K, Cipelli M, Tomaz V, Cortez LGF, de Franca Basto Silva M, Guedes RLM, Campregher PV, Rego EM, C\u00e2mara NOS, Costa-Lotufo LV, Machado-Neto JA (2026) Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia. Biochim Biophys Acta Mol Basis Dis 1872:168065. https:\/\/doi.org\/10.1016\/j.bbadis.2025.168065","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1084\/jem.20182044","volume":"216","author":"S Di Biase","year":"2019","unstructured":"Di Biase S, Ma X, Wang X, Yu J, Wang YC, Smith DJ, Zhou Y, Li Z, Kim YJ, Clarke N, To A, Yang L (2019) Creatine uptake regulates CD8 T cell antitumor immunity. J Exp Med 216:2869\u20132882. https:\/\/doi.org\/10.1084\/jem.20182044","journal-title":"J Exp Med"},{"key":"1943_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117111","volume":"240","author":"S Dong","year":"2025","unstructured":"Dong S, Yang R, Wang Y, Fang X, Han X, Gu M, Chen S, Zhang B (2025) A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway. Biochem Pharmacol 240:117111. https:\/\/doi.org\/10.1016\/j.bcp.2025.117111","journal-title":"Biochem Pharmacol"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.7150\/ijbs.83774","volume":"20","author":"W Du","year":"2024","unstructured":"Du W, Tu S, Zhang W, Zhang Y, Liu W, Xiong K, Zhou F, Li N, Zhang R, Yu J, Li M, Xiang W, Qian K, Wang G, Xiao Y, Wang X, Ju L (2024) UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT. Int J Biol Sci 20:1389\u20131409. https:\/\/doi.org\/10.7150\/ijbs.83774","journal-title":"Int J Biol Sci"},{"key":"1943_CR17","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12568","volume":"10","author":"Y Gao","year":"2022","unstructured":"Gao Y, Dai Z, Yang C, Wang D, Guo Z, Mao W, Chen Z (2022) Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma. PeerJ 10:e12568. https:\/\/doi.org\/10.7717\/peerj.12568","journal-title":"PeerJ"},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41586-025-08980-6","volume":"642","author":"M Gozdecka","year":"2025","unstructured":"Gozdecka M, Dudek M, Wen S, Gu M, Stopforth RJ, Rak J, Damaskou A, Grice GL, McLoughlin MA, Bond L, Wilson R, Giotopoulos G, Shanmugiah VM, Bakar RB, Yankova E, Cooper JL, Narayan N, Horton SJ, Asby R, Pask DC, Mupo A, Duddy G, Marando L, Georgomanolis T, Carter P, Ramesh AP, Dunn WG, Barcena C, Gallipoli P, Yusa K, Petrovski S, Wright P, Quiros PM, Frezza C, Nathan JA, Kaser A, Kar S, Tzelepis K, Mitchell J, Fabre MA, Huntly BJP, Vassiliou GS (2025) Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis. Nature 642:431\u2013441. https:\/\/doi.org\/10.1038\/s41586-025-08980-6","journal-title":"Nature"},{"key":"1943_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2026.121663","volume":"366","author":"X Han","year":"2026","unstructured":"Han X, Dong S, Wang Y, Fang X, Gu M, Li X, Wu Y, Zhang B (2026) Grape seed proanthocyanidin extract suppresses bladder cancer by dual blockade of IMPDH1\/2-mediated purine and pyrimidine nucleotide biosynthesis. J Ethnopharmacol 366:121663. https:\/\/doi.org\/10.1016\/j.jep.2026.121663","journal-title":"J Ethnopharmacol"},{"key":"1943_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115283","volume":"205","author":"K Hege Hurrish","year":"2022","unstructured":"Hege Hurrish K, Qiao X, Li X, Su Y, Carter J, Ma J, Kalpage HA, H\u00fcttemann M, Edwards H, Wang G, Kim S, Dombkowski A, Bao X, Li J, Taub JW, Ge Y (2022) Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia. Biochem Pharmacol 205:115283. https:\/\/doi.org\/10.1016\/j.bcp.2022.115283","journal-title":"Biochem Pharmacol"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.4161\/cc.9.9.11473","volume":"9","author":"T Ide","year":"2010","unstructured":"Ide T, Chu K, Aaronson SA, Lee SW (2010) GAMT joins the p53 network: branching into metabolism. Cell cycle (Georgetown, Tex) 9:1706\u20131710. https:\/\/doi.org\/10.4161\/cc.9.9.11473","journal-title":"Cell cycle (Georgetown, Tex)"},{"key":"1943_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107870","volume":"98","author":"M Jalili-Nik","year":"2021","unstructured":"Jalili-Nik M, Soltani A, Mashkani B, Rafatpanah H, Hashemy SI (2021) PD-1 and PD-L1 inhibitors foster the progression of adult T-cell leukemia\/lymphoma. Int Immunopharmacol 98:107870. https:\/\/doi.org\/10.1016\/j.intimp.2021.107870","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1943_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2022.02.006","volume":"40","author":"AK Jayavelu","year":"2022","unstructured":"Jayavelu AK, Wolf S, Buettner F, Alexe G, H\u00e4upl B, Comoglio F, Schneider C, Doebele C, Fuhrmann DC, Wagner S, Donato E, Andresen C, Wilke AC, Zindel A, Jahn D, Splettstoesser B, Plessmann U, M\u00fcnch S, Abou-El-Ardat K, Makowka P, Acker F, Enssle JC, Cremer A, Schn\u00fctgen F, Kurrle N, Chapuy B, L\u00f6ber J, Hartmann S, Wild PJ, Wittig I, H\u00fcbschmann D, Kaderali L, Cox J, Br\u00fcne B, R\u00f6llig C, Thiede C, Steffen B, Bornh\u00e4user M, Trumpp A, Urlaub H, Stegmaier K, Serve H, Mann M, Oellerich T (2022) The proteogenomic subtypes of acute myeloid leukemia. Cancer Cell 40(3):301. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.006","journal-title":"Cancer Cell"},{"key":"1943_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, Garcia-Manero G, Konopleva M, Ravandi F (2021) Acute myeloid leukemia: current progress and future directions. Blood Cancer J 11:41. https:\/\/doi.org\/10.1038\/s41408-021-00425-3","journal-title":"Blood Cancer J"},{"key":"1943_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08040-x","volume":"16","author":"SI Kawaguchi","year":"2025","unstructured":"Kawaguchi SI, Sato K, Izawa J, Takayama N, Hayakawa H, Tominaga K, Endo H, Kouki T, Ohno N, Kanda Y (2025) The combination of venetoclax with dimethyl fumarate synergistically induces apoptosis in AML cells by disrupting mitochondrial integrity through ROS accumulation. Cell Death Dis 16:750. https:\/\/doi.org\/10.1038\/s41419-025-08040-x","journal-title":"Cell Death Dis"},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.cmet.2021.05.012","volume":"33","author":"D Lagarde","year":"2021","unstructured":"Lagarde D, Kazak L (2021) Creatine promotes metastatic dissemination. Cell Metab 33:1065\u20131067. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.012","journal-title":"Cell Metab"},{"key":"1943_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051633","author":"B Li","year":"2021","unstructured":"Li B, Yang L (2021) Creatine in T cell antitumor immunity and cancer immunotherapy. Nutrients. https:\/\/doi.org\/10.3390\/nu13051633","journal-title":"Nutrients"},{"key":"1943_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1670895","volume":"15","author":"B Li","year":"2025","unstructured":"Li B, Jiang S, Xu Y, Yan X, Mu Q, Ouyang G (2025) Dual oncogenic role of RNF220 in AML: linking metabolic rewiring to cell proliferation and immune evasion. Front Oncol 15:1670895. https:\/\/doi.org\/10.3389\/fonc.2025.1670895","journal-title":"Front Oncol"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-023-06073-w","volume":"618","author":"ZC Nwosu","year":"2023","unstructured":"Nwosu ZC, Ward MH, Sajjakulnukit P, Poudel P, Ragulan C, Kasperek S, Radyk M, Sutton D, Menjivar RE, Andren A, Apiz-Saab JJ, Tolstyka Z, Brown K, Lee HJ, Dzierozynski LN, He X, Ps H, Ugras J, Nyamundanda G, Zhang L, Halbrook CJ, Carpenter ES, Shi J, Shriver LP, Patti GJ, Muir A, Pasca di Magliano M, Sadanandam A, Lyssiotis CA (2023) Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Nature 618:151\u2013158. https:\/\/doi.org\/10.1038\/s41586-023-06073-w","journal-title":"Nature"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","volume":"14","author":"AI Sheth","year":"2024","unstructured":"Sheth AI, Althoff MJ, Tolison H, Engel K, Amaya ML, Krug AE, Young TN, Minhajuddin M, Pei S, Patel SB, Winters A, Miller R, Shelton IT, St-Germain J, Ling T, Jones CL, Raught B, Gillen AE, Ransom M, Staggs S, Smith CA, Pollyea DA, Stevens BM, Jordan CT (2024) Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium. Cancer Discov 14:1922\u20131939. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1145","journal-title":"Cancer Discov"},{"key":"1943_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM (2025) Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol 100:860\u2013891. https:\/\/doi.org\/10.1002\/ajh.27625","journal-title":"Am J Hematol"},{"key":"1943_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s42255-023-00774-2","volume":"5","author":"OS Skinner","year":"2023","unstructured":"Skinner OS, Blanco-Fern\u00e1ndez J, Goodman RP, Kawakami A, Shen H, Kem\u00e9ny LV, Joesch-Cohen L, Rees MG, Roth JA, Fisher DE, Mootha VK, Jourdain AA (2023) Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions. Nat Metab 5:765\u2013776. https:\/\/doi.org\/10.1038\/s42255-023-00774-2","journal-title":"Nat Metab"},{"key":"1943_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07069-y","volume":"23","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen W, Wang Z, Cai S, Zhao X, Jin J, Gao T, Qu J (2025) Deciphering metabolic reprogramming of immune cells within the tumor microenvironment. J Transl Med 23:1055. https:\/\/doi.org\/10.1186\/s12967-025-07069-y","journal-title":"J Transl Med"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, Menk AV, Rittenhouse NL, DePeaux K, Whetstone RD, Vignali DAA, Hand TW, Poholek AC, Morrison BM, Rothstein JD, Wendell SG, Delgoffe GM (2021) Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591:645\u2013651. https:\/\/doi.org\/10.1038\/s41586-020-03045-2","journal-title":"Nature"},{"key":"1943_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.651687","volume":"12","author":"G Wells","year":"2021","unstructured":"Wells G, Kennedy PT, Dahal LN (2021) Investigating the role of indoleamine 2,3-dioxygenase in acute myeloid leukemia: a systematic review. Front Immunol 12:651687. https:\/\/doi.org\/10.3389\/fimmu.2021.651687","journal-title":"Front Immunol"},{"key":"1943_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116132","volume":"171","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li Y, Gao Y, Zhang P, Jing Q, Zhang Y, Jin W, Wang Y, Du J, Wu G (2024) Immunotherapies of acute myeloid leukemia: rationale, clinical evidence and perspective. Biomed Pharmacother 171:116132. https:\/\/doi.org\/10.1016\/j.biopha.2024.116132","journal-title":"Biomed Pharmacother"},{"key":"1943_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, Liang J, Tang Y, Su M, Luo X, Yang Y, Shi Y, Wang H, Zhou Y, Liao Q (2021) The cancer metabolic reprogramming and immune response. Mol Cancer 20:28. https:\/\/doi.org\/10.1186\/s12943-021-01316-8","journal-title":"Mol Cancer"},{"key":"1943_CR38","doi-asserted-by":"publisher","first-page":"113992","DOI":"10.1016\/j.biopha.2022.113992","volume":"157","author":"H Xiang","year":"2023","unstructured":"Xiang H, Yang R, Tu J, Xi Y, Yang S, Lv L, Zhai X, Zhu Y, Dong D, Tao X (2023) Metabolic reprogramming of immune cells in pancreatic cancer progression. Biomed Pharmacother 157:113992. https:\/\/doi.org\/10.1016\/j.biopha.2022.113992","journal-title":"Biomed Pharmacother"},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"112780","DOI":"10.1016\/j.ejmech.2020.112780","volume":"208","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhang XJ, Li WB, Wang XR, Wang S, Qiao XP, Chen SW (2020) Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. Eur J Med Chem 208:112780. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112780","journal-title":"Eur J Med Chem"},{"key":"1943_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40164-022-00332-8","volume":"11","author":"B Xu","year":"2022","unstructured":"Xu B, Zhou Z, Wen Y, Li Z, Huang Z, Li Y (2022) The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia. Experimental Hematol Oncol 11:81. https:\/\/doi.org\/10.1186\/s40164-022-00332-8","journal-title":"Experimental Hematol Oncol"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, Chu Q, Yuan X, Bao Z, Lu J, Li L (2023) Tryptophan metabolism in health and disease. Cell Metab 35:1304\u20131326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004","journal-title":"Cell Metab"},{"key":"1943_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y (2024) Cancer metabolism and carcinogenesis. Experimental Hematol Oncol 13:10. https:\/\/doi.org\/10.1186\/s40164-024-00482-x","journal-title":"Experimental Hematol Oncol"},{"key":"1943_CR46","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cmet.2021.03.009","volume":"33","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhu Z, Yan H, Wang W, Wu Z, Zhang F, Zhang Q, Shi G, Du J, Cai H, Zhang X, Hsu D, Gao P, Piao HL, Chen G, Bu P (2021) Creatine promotes cancer metastasis through activation of Smad2\/3. Cell Metab 33:1111-1123.e1114. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.009","journal-title":"Cell Metab"},{"key":"1943_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41419-022-04810-z","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang Y, Yin C, Gong P, Zhang Z, Zhao L, Waxman S, Jing Y (2022) Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa\/Bim\/Mcl-1\/p-Chk1 axis. Cell Death Dis 13:379. https:\/\/doi.org\/10.1038\/s41419-022-04810-z","journal-title":"Cell Death Dis"},{"key":"1943_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.870848","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Wang Y, Liu D, Luo Q, Du P, Zhang H, Wu W (2022) Sodium tanshinone IIA sulfonate as a potent IDO1\/TDO2 dual inhibitor enhances anti-PD1 therapy for colorectal cancer in mice. Front Pharmacol 13:870848. https:\/\/doi.org\/10.3389\/fphar.2022.870848","journal-title":"Front Pharmacol"},{"key":"1943_CR43","doi-asserted-by":"publisher","first-page":"102365","DOI":"10.1016\/j.xcrm.2025.102365","volume":"6","author":"D Zhang","year":"2025","unstructured":"Zhang D, Guo Y, Peng Z, Xiao Y, Chang Z, Yu L, Zhao Y, Zhang Q, Ma L, Li S, Li CK, Leung KT, Zhao ZJ, Chen C, Chen Y (2025) FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia. Cell Rep Med 6:102365. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102365","journal-title":"Cell Rep Med"},{"key":"1943_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404620","volume":"12","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhang H, Wang TY, Li M, Chan AKN, Kang H, Foong LC, Liu Q, Pokharel SP, Mattson NM, Singh P, Elsayed Z, Kuang B, Wang X, Rosen ST, Chen J, Yang L, Chou TF, Su R, Chen CD (2025) Nuclear control of mitochondrial homeostasis and venetoclax efficacy in AML via COX4I1. Adv Sci (Weinheim, Baden-Wurttemberg, Germany) 12:e2404620. https:\/\/doi.org\/10.1002\/advs.202404620","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"1943_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2166700","volume":"15","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Cai J, Hou W, Xu K, Wu X, Song Y, Bai C, Mo YY, Zhang Z (2023) Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice. Gut Microbes 15:2166700. https:\/\/doi.org\/10.1080\/19490976.2023.2166700","journal-title":"Gut Microbes"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01943-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:36:18Z","timestamp":1781674578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01943-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01943-8","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"148"}}